Loading...
Thumbnail Image
Publication

New onset seizures in the elderly: aetiology and prognosis.

Timmons, S
Sweeney, B
Hyland, M
O'Mahony, D
Twomey, C
Advisors
Editors
Other Contributors
Date
2012-02-03T15:10:43Z
Date Submitted
Keywords
Other Subjects
Subject Mesh
Age Factors
Aged
Aged, 80 and over
Anticonvulsants/therapeutic use
Comorbidity
Epilepsy/*epidemiology/etiology/mortality/prevention & control
Follow-Up Studies
Humans
Incidence
Prognosis
Retrospective Studies
Time Factors
Planned Date
Start Date
Collaborators
Principal Investigators
Alternative Titles
Publisher
Abstract
Late onset epilepsy is increasing in incidence. These patients often have significant underlying morbidity. This retrospective study in a tertiary referral centre identified 68 patients aged 65 years or older, with new onset seizures over a four-year period. 81% of patients (n = 55) were followed up at an average of 2.7 years post diagnosis. 38% of patients had evidence of cerebrovascular disease (CT visualised focal infarction, haemorrhage or small vessel ischaemia in 32%, clinical diagnosis with normal CT brain in 6%). No patient was found to have a space-occupying lesion. Of the 55 patients followed up, 45% of these had died at a mean age of 82 years old and 1.9 years post diagnosis (range 12 hours to 5 years). Three patients died as a direct result of seizures (trauma and sepsis). 14 patients died of clearly unrelated causes. Eight patients died from underlying vascular disease or Alzheimer's dementia. Patients who died during follow-up were on average 3.4 years older at the time of diagnosis than survivors (p< 0.05). Patients with atrial fibrillation at the time of diagnosis, had increased mortality (relative risk 2.53; 95% C.I. 1.19 - 5.36), but they were older than those without atrial fibrillation. At the time of follow up, 92% of those taking anti-convulsants were maintained seizure free on anticonvulsant monotherapy.
Language
eng
ISSN
0332-3102 (Print)
0332-3102 (Linking)
eISSN
ISBN
DOI
PMID
11989947
PMCID
Sponsorships
Funding Sources
Funding Amounts
Grant Identifiers
Methodology
Duration
Ethical Approval